PFE: Pfizer, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 187,772.69
Enterprise Value ($M) 236,297.77
Book Value ($M) 58,806.00
Book Value / Share 10.63
Price / Book 3.36
NCAV ($M) -50,973.00
NCAV / Share -9.21
Price / NCAV -3.78

Profitability (mra)
Return on Invested Capital (ROIC) 0.11
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.16

Liquidity (mrq)
Quick Ratio 1.27
Current Ratio 1.54

Balance Sheet (mrq) ($M)
Current Assets 45,290.00
Assets 155,000.00
Liabilities 96,263.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income n/a
Net Income 11,188.00
Earnings Per Share Diluted 1.87
Earnings Per Share Basic 1.90

Cash Flow Statement (mra) ($M)
Cash From Operations 15,827.00
Cash from Investing 4,525.00
Cash from Financing 4,525.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2020-02-13 13G State Street Corp 5.28 -1.21
2020-02-12 13G/A Vanguard Group Inc 8.13 -0.36
2020-02-05 13G/A BlackRock Inc. 7.70 -7.91

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2019-11-07 10-Q PFE / Pfizer, Inc. 10-Q – Quarterly Report – 10-Q
2019-08-08 10-Q PFE / Pfizer, Inc. 10-Q – Quarterly Report – 10-Q
2019-05-09 10-Q PFE / Pfizer, Inc. 10-Q Quarterly Report 10-Q
2019-02-28 10-K PFE / Pfizer, Inc. FORM 10-K (Annual Report)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2020-02-25 3,910,472 39,733,200 9.84
2020-02-24 3,156,472 36,024,000 8.76
2020-02-21 1,806,160 30,763,900 5.87
2020-02-20 2,735,389 40,752,400 6.71

(click for more detail)

Similar Companies
MNK – Maillinckrodt plc. MRK – Merck & Co., Inc.
PBH – Prestige Brands Holdings, Inc. PRGO – Perrigo Company plc
USNA – USANA Health Sciences, Inc.


Financial data and stock pages provided by
Fintel.io